My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 283

    1.

    Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines.

    Scull MA, Ploss A.

    Hepatology. 2012 Feb;55(2):645-8. doi: 10.1002/hep.24716. No abstract available.

    PMID:
    22287293
    [PubMed]

    Related citations

    2.

    High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.

    Scholtes C, Ramière C, Rainteau D, Perrin-Cocon L, Wolf C, Humbert L, Carreras M, Guironnet-Paquet A, Zoulim F, Bartenschlager R, Lotteau V, André P, Diaz O.

    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25628. [Epub ahead of print]

    PMID:
    22290760
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.

    Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Márquez-Solero M, Omar M, Macías J, Camacho A, Pérez-Pérez M, Gómez-Mateos J, Rivero A, Pineda JA; on behalf of the Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616. [Epub ahead of print]

    PMID:
    22278746
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.

    Rasmussen AL, Tchitchek N, Susnow NJ, Krasnoselsky AL, Diamond DL, Yeh MM, Proll SC, Korth MJ, Walters KA, Lederer S, Larson AM, Carithers RL, Benecke A, Katze MG.

    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25612. [Epub ahead of print]

    PMID:
    22278598
    [PubMed - as supplied by publisher]

    Related citations

    5.

    A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.

    D'Ambrosio R, Aghemo A, Grazia Rumi M, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P.

    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606. [Epub ahead of print]

    PMID:
    22271347
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Association between IL28B-related genetic variants and liver histopathology differs between hcv genotypes.

    Rembeck K, Westin J, Lindh M, Hellstrand K, Norkrans G, Lagging M; for the NORDynamIC study group.

    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25598. [Epub ahead of print] No abstract available.

    PMID:
    22270967
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.

    Fischer J, Böhm S, Scholz M, Müller T, Witt H, George J, Sarrazin C, Susser S, Schott E, Suppiah V, Booth DR, Stewart GJ, van Bömmel F, Brodzinski A, Fülöp B, Migaud P, Berg T.

    Hepatology. 2012 Jun;55(6):1700-10. doi: 10.1002/hep.25582. Epub 2012 Apr 18.

    PMID:
    22234924
    [PubMed - in process]

    Related citations

    8.

    Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052.

    Sun JH, O'Boyle Ii DR, Zhang Y, Wang C, Nower P, Valera L, Roberts S, Nettles RE, Fridell RA, Gao M.

    Hepatology. 2012 Jun;55(6):1692-9. doi: 10.1002/hep.25581.

    PMID:
    22234905
    [PubMed - in process]

    Related citations

    9.

    Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.

    Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC.

    Hepatology. 2012 Jun;55(6):1684-91. doi: 10.1002/hep.25575. Epub 2012 Apr 18.

    PMID:
    22234804
    [PubMed - in process]

    Related citations

    10.

    Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.

    Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ.

    Hepatology. 2012 Jun;55(6):1673-83. doi: 10.1002/hep.25562. Epub 2012 Apr 18.

    PMID:
    22213147
    [PubMed - in process]

    Related citations

    11.

    Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

    Denniston MM, Klevens RM, McQuillan GM, Jiles RB.

    Hepatology. 2012 Jun;55(6):1652-61. doi: 10.1002/hep.25556. Epub 2012 Apr 10.

    PMID:
    22213025
    [PubMed - in process]

    Related citations

    12.

    Prioritizing treatment experienced patients with hepatitis C infection for treatment with telaprevir: a number needed to treat approach.

    Rowe IA, Armstrong MJ, Houlihan DD.

    Hepatology. 2012 May;55(5):1644-5. doi: 10.1002/hep.25553. No abstract available.

    PMID:
    22212958
    [PubMed - in process]

    Related citations

    13.

    Effect of interleukin-28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with pegylated interferon alpha-2a/ribavirin.

    Pearlman BL, Ehleben C.

    Hepatology. 2012 May;55(5):1645. doi: 10.1002/hep.25552. No abstract available.

    PMID:
    22212908
    [PubMed - in process]

    Related citations

    14.

    Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.

    Reddy SK, Steel JL, Chen HW, Demateo DJ, Cardinal J, Behari J, Humar A, Marsh JW, Geller DA, Tsung A.

    Hepatology. 2012 Jun;55(6):1809-19. doi: 10.1002/hep.25536. Epub 2012 Apr 23.

    PMID:
    22183968
    [PubMed - in process]

    Related citations

    15.

    A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A-mediated translation and virus production.

    Khachatoorian R, Arumugaswami V, Ruchala P, Raychaudhuri S, Maloney EM, Miao E, Dasgupta A, French SW.

    Hepatology. 2012 Jun;55(6):1662-72. doi: 10.1002/hep.25533. Epub 2012 Jan 30.

    PMID:
    22183951
    [PubMed - in process]

    Related citations

    16.

    The end of the beginning for hepatitis C treatment.

    Dieterich D.

    Hepatology. 2012 Mar;55(3):664-5. doi: 10.1002/hep.25528. No abstract available.

    PMID:
    22174100
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Diagnostic algorithms for liver fibrosis in hepatitis C: are they ready to avoid liver biopsy?

    Sebastiani G, Alberti A.

    Hepatology. 2012 Feb;55(2):652-3; author reply 653. doi: 10.1002/hep.25517. No abstract available.

    PMID:
    22162013
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments.

    Cobb B, Vilchez RA.

    Hepatology. 2012 Mar;55(3):979-80; author reply 980-1. doi: 10.1002/hep.25516. No abstract available.

    PMID:
    22161994
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Error occurred: cannot get document summary

    PMID:
    22161637

    20.

    The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction.

    Quarato G, D'Aprile A, Gavillet B, Vuagniaux G, Moradpour D, Capitanio N, Piccoli C.

    Hepatology. 2012 May;55(5):1333-43. doi: 10.1002/hep.25514. Epub 2012 Mar 18.

    PMID:
    22135208
    [PubMed - in process]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk